![Suven Pharmaceuticals Limited logo](/logos/SUVENPHAR.NS.webp)
Suven Pharmaceuticals Limited
NSE:SUVENPHAR.NS
Overview | Financials
Company Name | Suven Pharmaceuticals Limited |
Symbol | SUVENPHAR.NS |
Currency | INR |
Price | 1,200.15 |
Market Cap | 305,516,184,750 |
Dividend Yield | 0% |
52-week-range | 507 - 1,224 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Venkateswarlu Jasti M.Pharm. M.S. |
Website | https://www.suvenpharm.com |
An error occurred while fetching data.
About Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD